Israel Active

Scientists at Israel’s Weizmann Institute and in Germany, have clarified the molecular cascade triggered by ketamine, that leads to its sustained antidepressant effects. They found that the gene Kcnq2 enables potassium ions to pass through the brain, maintaining the activity and stability of neurons.

Excellent article about Israel’s DecideVR (see previously) - the most advanced Virtual Reality simulator for reducing errors and saving lives in Intensive Care Units. It was developed by Prof Alex Mintz, Director of the Computerized Decision-Making Lab at Reichman University.

Since March, volunteer doctors (Jews & Arabs) from the Hadassah Medical Organization in Jerusalem, have been running the medical clinic at the Przemyśl Humanitarian Aid Center, near the Medyka border crossing in southeastern Poland. Also, at a refugee center in nearby Korczowa.

Surgeons at Jerusalem’s Hadassah hospital performed a “first time in Israel” aortic valve transplant to save a patient unsuitable for open-heart surgery. The hybrid team of catheterization specialists and cardiac surgeons used the carotid artery as the point of entry.

Israel’s MEDX Xelerator (see previously) has partnered with the Portland Trust to launch an incubator branch in the Sakhnin Valley region in northern Israel. It will support health and medical startups in the Galilee and northern Arab and Jewish regions.

Some 1,000 people registered to attend Israel’s first mental health expo. It was conducted entirely in English and tailored to the needs of English-speaking immigrants. Its aim was to give a sense of what’s available in Israel to help and treat people facing mental health challenges.

According to new data from Israel’s Health Ministry, the number of serious coronavirus cases in Israel has dipped below 100 for the first time since end Dec 2021. On 15th May there were only some 15,500 active Covid-19 infections in Israel.

A team of international scientists, led by Dr. Gad Vatine of Ben Gurion University, discovered a thyroid hormone MCT8 mutation causes Allan-Herndon-Dudley syndrome (AHDS). Sufferers cannot walk or talk. They developed a gene therapy AAV9-MCT8 to restore the hormone’s function.

Researchers at Tel Aviv University found that a mutation in genes ADNP and SHANK3 causes conditions such as autism, schizophrenia, and neuro-degenerative diseases like Alzheimer's. They also found that an experimental therapy Davunetide can counter the effects of the mutation.

MesenCure – the life-saving Covid-19 treatment from Israel’s Bonus BioGroup (see ) also prevents a lethal inflammatory response that affects cancer patients receiving immunotherapy. In California trials MesenCure significantly reduced an overreaction of the immune system.